Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Optherion Inc.
DescriptionRecombinant form of the protective variant of complement factor H (rhCFH)
Molecular Target Complement factor H (factor H) (CFH)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationAge-related macular degeneration (AMD)
Indication DetailsTreat age-related macular degeneration (AMD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today